Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > where is the news
View:
Post by KVDollars on Feb 22, 2021 2:34pm

where is the news

ya bunch of fools
Comment by Jonnyboy85 on Feb 22, 2021 7:48pm
Sorry, I get that intelligence isn't your strong suit, you know, since your chosen career path is bashing on public chat rooms for drug money, but the last time I checked Q1 lasts until the end of March. More reading and less meth will help your bashing game.
Comment by SAGDollar on Feb 22, 2021 8:02pm
You sound desperate Jonny
Comment by Jonnyboy85 on Feb 22, 2021 8:14pm
Oh ya? You're telling me that all the longs sacrificing their accounts to bash at the 11th hour for a better position aren't desperate, but the guy calling them out is? Hmmm desperate are the people that are on the outside looking in while we're hovering around our annual high pending news, not guys like me who held every share I ever bought. Looks to me like we're in the best spot ...more  
Comment by LithLover on Feb 22, 2021 8:48pm
Aristotle is not the same as filing quarterly results on sedar at midnight on the day due.   Over promise under deliver       
Comment by Jonnyboy85 on Feb 22, 2021 8:59pm
Please enlighten us on the process then? Are you saying that because Aristotle has not launched yet, that it won't or can't? Quite the allegation there for someone who's apparently long. Hey anyone else seen so many "longs" attempt to sow doubt in a public chat room against their own investment before?? Lol ya me either, funny way of showing your support.
Comment by LithLover on Feb 22, 2021 9:54pm
Pretty defensive there Jonny.  I meant let's not wait until the last day.  They did that on the last financials and than had to report again due to incorrect warrant calculations.  So let's roll out before the end of March.  Nothing wrong with over delivering instead of just meeting expectations or disappointing because of unforeseen delays or missteps    ...more  
Comment by Jonnyboy85 on Feb 22, 2021 9:57pm
No, not defensive, I just care about Cancer and have morals, and I dislike those who don't. In case you didn't notice.
Comment by RelevantStock on Feb 22, 2021 9:09pm
Not sure I understand, what's wrong?.. The lab is printing money rn and they announced Aristotle for Q1 on multiple platforms.
Comment by Jonnyboy85 on Feb 22, 2021 9:40pm
Sounds like buying talk to me. Sad to see all these accounts turn on everyone and start selfishly trying to manipulate people here to bolster their position before Aristotle and Q4/Q1 rev reporting. Look at the charts, the markets already decided what direction this stock was going months ago. quit giving in to your ugliest sides and buy back, join the party
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities